Correlation between metastatic site and response to anti-Programmed Death-1 (PD-1) agents in melanoma.

被引：15
|
作者：
Goldinger, Simone M.
Tsai, Katy K.
Tumeh, Paul
Hamid, Omid
Nosrati, Adi
Loo, Kimberly
Grimes, Barbara
Algazi, Alain Patrick
Levesque, Mitchell P.
Dummer, Reinhard
Daud, Adil
机构：
[1] Univ Zurich Hosp, Zurich, Switzerland
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Angeles Clin & Res Inst, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.9549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9549
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Adverse events associated with "Anti-programmed death-1" therapy for patients with melanoma
    De Francesco, Adele Emanuela
    De Fina, Mariarosanna
    Zito, Maria Cristina
    Bisceglia, Maria Dezia
    Esposito, Stefania
    Fersini, Giuseppina
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [22] Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma
    Lee, Joycelyn J. X.
    Chan, Alexandre
    Tang, Tiffany
    [J]. ACTA ONCOLOGICA, 2016, 55 (04) : 519 - 520
  • [23] Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents
    Weber, Jeffrey S.
    Postow, Michael
    Lao, Christopher D.
    Schadendorf, Dirk
    [J]. ONCOLOGIST, 2016, 21 (10): : 1230 - 1240
  • [24] Autoimmune diabetes and anti-programmed cell death-1 (anti-PD-1) cancer immunotherapy
    Daltry, S.
    Bujanova, J.
    Cranston, I.
    [J]. DIABETIC MEDICINE, 2017, 34 : 102 - 102
  • [25] Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapy
    Zhou, Li
    Shao, Lizhi
    Gao, Shunyu
    Cui, Chuanliang
    Chi, Zhihong
    Sheng, Xinan
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Yan, Xieqiao
    Wang, Xuan
    Bai, Xue
    Li, Siming
    Guo, Jun
    Si, Lu
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (01) : 112 - 121
  • [26] Anti-Programmed Death 1 (PD-1) Antibodies and the Pancreas: A Diabetic Storm Ahead?
    Marchand, Lucien
    Thivolet, Arnaud
    Saintigny, Pierre
    Fabien, Nicole
    Vouillarmet, Julien
    Thivolet, Charles
    [J]. DIABETES CARE, 2018, 41 (03) : 638 - 639
  • [27] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Naidoo, Jarushka
    Wang, Xuan
    Woo, Kaitlin M.
    Iyriboz, Tunc
    Halpenny, Darragh
    Cunningham, Jane
    Chaft, Jamie E.
    Segal, Neil H.
    Callahan, Margaret K.
    Lesokhin, Alexander M.
    Rosenberg, Jonathan
    Voss, Martin H.
    Rudin, Charles M.
    Rizvi, Hira
    Hou, Xue
    Rodriguez, Katherine
    Albano, Melanie
    Gordon, Ruth-Ann
    Leduc, Charles
    Rekhtman, Natasha
    Harris, Bianca
    Menzies, Alexander M.
    Guminski, Alexander D.
    Carlino, Matteo S.
    Kong, Benjamin Y.
    Wolchok, Jedd D.
    Postow, Michael A.
    Long, Georgina V.
    Hellmann, Matthew D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 709 - +
  • [28] Predictive markers for programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis blockade therapy in patients with metastatic melanoma (MM).
    Kim, Dae Won
    Chakravarti, Nitin
    Trinh, VanAnh
    Perdon, Karen Mae
    McIntyre, Susan E.
    Prieto, Victor G.
    Hwu, Wen-Jen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Integrated safety analysis of anti-programmed cell death-1 (PD-1) antibody penpulimab in advanced solid tumour or lymphoma
    Xu, N.
    Han, B.
    Jiao, S.
    Hu, C.
    Mislang, A.
    Coward, J.
    Cooper, A.
    Underhill, C.
    Xia, Y.
    Xia, D.
    Jin, X.
    Wang, Z. M.
    Li, B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1428 - S1429
  • [30] Patient human leukocyte antigen (HLA) genotype may predict response to anti-programmed death receptor 1 (anti-PD1) in advanced melanoma.
    Oey, Oliver
    Khattak, Muhammad Adnan
    Abed, Afaf
    Meniawy, Tarek
    Reid, Anna
    Calapre, Leslie
    Millward, Michael
    Gray, Elin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345